Breaking News

Axogen (NASDAQ: AXGN) announced their quarterly financial results on March 5, 2024. They reported a loss of $(0.06) per share,...

American Airlines is paving the way for a resilient future in the airline industry. They prioritize safety, support diverse talent,...

Praxis Precision Medicine (NASDAQ: PRAX) announced their fourth-quarter earnings on March 5, 2024, with an EPS of $(2.97), beating expectations...

AECOM, a global infrastructure firm, has been selected by Amtrak to collaborate on the ambitious $1.5 billion Susquehanna River Rail...

As of March 5, 2024, analysts are expressing a range of positive sentiments towards Avidity Biosciences (NASDAQ: RNA). Within the...

Analyst projections for bluebird bio (NASDAQ: BLUE) are varied, with a range of viewpoints from bullish to bearish. In the...

UBS analyst Douglas Harter is optimistic about Redwood Trust (NYSE: RWT), maintaining a Buy rating on the stock. However, he...

Barclays analyst Matt Miksic has reiterated his Underweight rating on ZimVie (NASDAQ: ZIMV) with a revised price target. The new...

On March 5, 2024, analyst Oren Livnat from HC Wainwright & Co. reiterated a bullish stance on Zevra Therapeutics (NASDAQ:...

Target's stock is on the rise following a strong Q4 earnings report and a positive forecast for FY24. The company...